Clinical Trial

A Study to Evaluate CM336 in Adults With Autoimmune Bullous Disease

Name: A Study to Evaluate CM336 in Adults With Autoimmune Bullous Disease — clinical trial record (NCT06900010)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

to Evaluate the Efficacy and Safety of CM336 (BCMA/CD3 Bispecific Antibody) in Adults with Moderate to Severe Autoimmune Bullous Disease

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-03-23.

Trial Details

NCT Number	NCT06900010
Lead Sponsor	Shandong First Medical University
Conditions	Autoimmune Bullous Disease
Enrollment	30 participants
Start Date	2025-04-22
Primary Completion	2027-01-01 (estimated)
Study Completion	2028-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-06